217 related articles for article (PubMed ID: 26618703)
1. Ribosomal L22-like1 (RPL22L1) Promotes Ovarian Cancer Metastasis by Inducing Epithelial-to-Mesenchymal Transition.
Wu N; Wei J; Wang Y; Yan J; Qin Y; Tong D; Pang B; Sun D; Sun H; Yu Y; Sun W; Meng X; Zhang C; Bai J; Chen F; Geng J; Lee KY; Fu S; Jin Y
PLoS One; 2015; 10(11):e0143659. PubMed ID: 26618703
[TBL] [Abstract][Full Text] [Related]
2. JMJD2B promotes epithelial-mesenchymal transition by cooperating with β-catenin and enhances gastric cancer metastasis.
Zhao L; Li W; Zang W; Liu Z; Xu X; Yu H; Yang Q; Jia J
Clin Cancer Res; 2013 Dec; 19(23):6419-29. PubMed ID: 24077348
[TBL] [Abstract][Full Text] [Related]
3. Human chorionic gonadotropin β regulates epithelial-mesenchymal transition and metastasis in human ovarian cancer.
Liu N; Peng SM; Zhan GX; Yu J; Wu WM; Gao H; Li XF; Guo XQ
Oncol Rep; 2017 Sep; 38(3):1464-1472. PubMed ID: 28713970
[TBL] [Abstract][Full Text] [Related]
4. Wnt3a expression is associated with epithelial-mesenchymal transition and promotes colon cancer progression.
Qi L; Sun B; Liu Z; Cheng R; Li Y; Zhao X
J Exp Clin Cancer Res; 2014 Dec; 33(1):107. PubMed ID: 25499541
[TBL] [Abstract][Full Text] [Related]
5. MiR-361-5p decreases the tumorigenicity of epithelial ovarian cancer cells by targeting at RPL22L1 and c-Met signaling.
Ma J; Jing X; Chen Z; Duan Z; Zhang Y
Int J Clin Exp Pathol; 2018; 11(5):2588-2596. PubMed ID: 31938372
[TBL] [Abstract][Full Text] [Related]
6. BRMS1L suppresses ovarian cancer metastasis via inhibition of the β-catenin-wnt pathway.
Cao P; Zhao S; Sun Z; Jiang N; Shang Y; Wang Y; Gu J; Li S
Exp Cell Res; 2018 Oct; 371(1):214-221. PubMed ID: 30118697
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA TC0101441 induces epithelial-mesenchymal transition in epithelial ovarian cancer metastasis by downregulating KiSS1.
Qiu JJ; Lin XJ; Tang XY; Zheng TT; Zhang XY; Hua KQ
Int J Cancer; 2020 May; 146(9):2588-2598. PubMed ID: 31577838
[TBL] [Abstract][Full Text] [Related]
8. Identification of candidate diagnostic and prognostic biomarkers for human prostate cancer: RPL22L1 and RPS21.
Liang Z; Mou Q; Pan Z; Zhang Q; Gao G; Cao Y; Gao Z; Pan Z; Feng W
Med Oncol; 2019 May; 36(6):56. PubMed ID: 31089825
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of Tripartite Motif Containing 28 suppresses the migration, invasion and epithelial-mesenchymal transition in ovarian carcinoma cells through down-regulation of Wnt/β-catenin signaling pathway.
Deng B; Zhang S; Zhang Y; Miao Y; Meng X; Guo K
Neoplasma; 2017; 64(6):893-900. PubMed ID: 28895414
[TBL] [Abstract][Full Text] [Related]
10. Ribosomal protein L22-like1 promotes prostate cancer progression by activating PI3K/Akt/mTOR signalling pathway.
Yi X; Zhang C; Liu B; Gao G; Tang Y; Lu Y; Pan Z; Wang G; Feng W
J Cell Mol Med; 2023 Feb; 27(3):403-411. PubMed ID: 36625246
[TBL] [Abstract][Full Text] [Related]
11. Alteration of epithelial-mesenchymal transition markers in human normal ovaries and neoplastic ovarian cancers.
Yi BR; Kim TH; Kim YS; Choi KC
Int J Oncol; 2015 Jan; 46(1):272-80. PubMed ID: 25310727
[TBL] [Abstract][Full Text] [Related]
12. PRKAR2B promotes prostate cancer metastasis by activating Wnt/β-catenin and inducing epithelial-mesenchymal transition.
Sha J; Han Q; Chi C; Zhu Y; Pan J; Dong B; Huang Y; Xia W; Xue W
J Cell Biochem; 2018 Sep; 119(9):7319-7327. PubMed ID: 29761841
[TBL] [Abstract][Full Text] [Related]
13. TRAP1 downregulation in human ovarian cancer enhances invasion and epithelial-mesenchymal transition.
Amoroso MR; Matassa DS; Agliarulo I; Avolio R; Lu H; Sisinni L; Lettini G; Gabra H; Landriscina M; Esposito F
Cell Death Dis; 2016 Dec; 7(12):e2522. PubMed ID: 27977010
[TBL] [Abstract][Full Text] [Related]
14. CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion.
Cho SH; Park YS; Kim HJ; Kim CH; Lim SW; Huh JW; Lee JH; Kim HR
Int J Oncol; 2012 Jul; 41(1):211-8. PubMed ID: 22552741
[TBL] [Abstract][Full Text] [Related]
15. A role for cancer-associated fibroblasts in inducing the epithelial-to-mesenchymal transition in human tongue squamous cell carcinoma.
Zhou B; Chen WL; Wang YY; Lin ZY; Zhang DM; Fan S; Li JS
J Oral Pathol Med; 2014 Sep; 43(8):585-92. PubMed ID: 24645915
[TBL] [Abstract][Full Text] [Related]
16. α-Smooth muscle actin-positive myofibroblasts, in association with epithelial-mesenchymal transition and lymphogenesis, is a critical prognostic parameter in patients with oral tongue squamous cell carcinoma.
Ding L; Zhang Z; Shang D; Cheng J; Yuan H; Wu Y; Song X; Jiang H
J Oral Pathol Med; 2014 May; 43(5):335-43. PubMed ID: 24313357
[TBL] [Abstract][Full Text] [Related]
17. Selenium-enriched polysaccharides from Pyracantha fortuneana (Se-PFPs) inhibit the growth and invasive potential of ovarian cancer cells through inhibiting β-catenin signaling.
Sun Q; Dong M; Wang Z; Wang C; Sheng D; Li Z; Huang D; Yuan C
Oncotarget; 2016 May; 7(19):28369-83. PubMed ID: 27058760
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis.
Wang H; Zhang H; Tang L; Chen H; Wu C; Zhao M; Yang Y; Chen X; Liu G
Toxicology; 2013 Jan; 303():139-46. PubMed ID: 23146760
[TBL] [Abstract][Full Text] [Related]
19. SATB1 promotes prostate cancer metastasis by the regulation of epithelial-mesenchymal transition.
Mao LJ; Yang CH; Fan L; Gao P; Yang DR; Xue BX; Zheng JN; Shan YX
Biomed Pharmacother; 2016 Apr; 79():1-8. PubMed ID: 27044805
[TBL] [Abstract][Full Text] [Related]
20. MDC1 promotes ovarian cancer metastasis by inducing epithelial-mesenchymal transition.
Liu X; Dong R; Jiang Z; Wei Y; Li Y; Wei L; Sun H; Li Y; Yang N; Yang Q; Liu Z; Kong B
Tumour Biol; 2015 Jun; 36(6):4261-9. PubMed ID: 25592380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
